Background: As endovascular aneurysm repair (EVAR) continues to advance, eligibility of patients with anatomically complex abdominal aortic aneurysms (AAAs) for EVAR is increasing. However, whether complex EVAR is associated with favorable outcome over conventional open repair and how outcomes compare with infrarenal EVAR remains unclear. This study examined perioperative outcomes of patients undergoing complex EVAR, focusing on differences with complex open repair and standard infrarenal EVAR.
Endovascular abdominal aortic aneurysm (AAA) repair (EVAR) is associated with lower perioperative mortality and lower rates of complications, need for transfusions, and length of stay compared with open repair. [1] [2] [3] [4] These benefits have resulted in the rapid increase of EVAR use since its introduction in 1996, 5 with >80% of infrarenal AAA repairs now being performed using endovascular treatment. [6] [7] [8] As a result of inadequate proximal seal zone, standard EVAR cannot be used for juxtarenal and suprarenal aneurysms (complex AAA), which has been reported to comprise as much as 20% of all AAAs. [9] [10] [11] Through advancements in endovascular treatment techniques, including chimney, fenestrated, and branched stent grafts, EVAR can now be offered to patients with complex proximal neck anatomy. 12 A large national series from the United Kingdom demonstrated that fenestrated EVAR can be performed with a high degree of technical and clinical success. 13 However, most feasibility studies are institutional based and are therefore often limited to small numbers of patients.
benefits favoring EVAR, 22, 23 but another review demonstrated a pooled perioperative mortality of 4.1% after both EVAR and open repair, with no difference in the complication rate. 24 In addition, the association of complex EVAR with an increased risk of postoperative renal failure compared with uncomplicated infrarenal EVAR has been suggested. 25, 26 However, limited comparative data exist for infrarenal vs complex EVAR, and the presumed differences in renal complications could previously not be confirmed. 27 The purpose of this study was to assess the perioperative outcome after EVAR for complex aneurysms, focusing on differences with complex open repair, the alternative treatment option, and standard infrarenal EVAR using the newly available American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) Targeted Vascular data set.
METHODS
The ACS NSQIP is a multi-institutional collaboration with 102 participating hospitals in the United States that prospectively collect clinical data of patients undergoing major surgery. The NSQIP database includes demographics, comorbidities, intraoperative characteristics, and 30-day postoperative outcomes. For this study, we used the ACS NSQIP Targeted Vascular data set, a recently added module that includes additional disease and procedure-specific characteristics and procedure-related outcomes chosen by vascular surgeons. All data collection is performed by trained clinical nurse reviewers and data abstractors. The validity of the ACS NSQIP has been confirmed in previous reports. [28] [29] [30] 31 Early conversions were considered an outcome for EVAR patients and are therefore included in all analyses as EVAR patients.
The remaining cohort was subsequently divided in three groups in accordance with treatment modality and proximal aneurysm extent: complex EVAR, complex open repair, and infrarenal EVAR. A complex aneurysm was defined as an aneurysm with a juxtarenal or suprarenal proximal extent. Aneurysms coded as pararenal, which is separately defined as an AAA involving the origin of the renal arteries according to the NSQIP, were also considered complex. Data on the proximal extent of the aneurysm were obtained directly from operative reports by trained clinical reviewers. All aneurysms treated with the Zenith Fenestrated endograft (Cook Medical, Bloomington, Ind), which is currently the only fenestrated graft approved by the United States Food and Drug Administration, were also considered complex.
Complex open repair patients with infrarenal aortic clamping were excluded. For patients undergoing open repair, a visceral vessel reconstruction was defined as mentioning of a CPT code for visceral vessel reconstruction (35361) or mentioning of a visceral vessel reconstruction in the Targeted Vascular module.
Groups were compared on baseline and operative characteristics as well as postoperative outcomes. Postoperative outcomes included 30-day mortality and in-hospital adverse outcomes such renal function deterioration, ischemic colitis, leg ischemia, wound complications, shock, sepsis, and intensive care unit (ICU) and hospital length of stay. Renal function deterioration was defined as either or both of a rise in creatinine of >2 mg/dL from the preoperative value or requirement of hemodialysis, peritoneal dialysis, hemofiltration, hemodiafiltration, or ultrafiltration #30 days of the operation. Patients on dialysis preoperatively were excluded for analysis of renal outcomes. Ischemic colitis was defined as having symptoms of ischemic colitis or confirmation of the diagnosis on diagnostic sigmoidoscopy or colonoscopy, or both. Patients with systemic inflammatory response syndrome, sepsis, or septic shock preoperatively were not included for postoperative sepsis and shock analysis. Wound complications included superficial, deep, and organ space infections. To identify differences in postoperative morbidity aside from death, 30-day mortality was not included in the any complication variable.
Statistical analyses. Categoric variables are presented as counts and percentages and continuous variables as mean (standard deviation). Differences between treatment groups were assessed using c 2 and Fisher exact tests for categoric variables and the Student t-test for continuous variables, where appropriate. To assess independent risks associated with treatment approaches, we used multivariable logistic regression analysis. Baseline characteristics were univariately tested, and predictors with a P value of <.1 were added to the multivariable model. Age was included in all models, regardless of the univariable association. Risk-adjusted comparisons of complex EVAR with complex open repair and infrarenal EVAR were performed separately, and different models were constructed for each analysis. All tests were two-sided, and significance was considered when the P value was <.05. Statistical analysis was performed using IBM SPSS Statistics 21 software (IBM Inc, Armonk, NY). P ¼ .005). The complex EVAR patients more often had insulin-dependent diabetes (3.9% vs 1.3% P ¼ .019), had a higher preoperative creatinine (1.22 vs 1.09 mg/dL, P ¼ .006), and were more commonly on dialysis (2.9% vs 0.8%; P ¼ .034). Conversely, complex EVAR patients were less often current smokers (29.2% vs 45.6%; P < .001). When the complex EVAR patients were compared with the infrarenal EVAR patients, those undergoing repair for a complex AAA were more commonly dialysis dependent (2.9% vs 0.9%; P < .001), more often had heart failure (4.1% vs 1.6%; P < .001), and tended toward a higher preoperative creatinine (1.22 vs 1.14 mg/dL; P ¼ .055). In addition, obesity, defined as a body mass index >30 kg/m 2 , was less common among complex EVAR patients than among infrarenal EVAR patients (26.8% vs 31.7%; P ¼ .040).
RESULTS

Included
Operative and anatomical characteristics. Complex EVAR was associated with shorter operative time compared with complex open repair (184 vs 269 minutes; P < .001), but took significantly longer than infrarenal Postoperative outcomes. Postoperative outcomes are detailed in Table III , A. Mortality #30 days was significantly lower after complex EVAR than after complex open repair (3.4% vs 6.6%; P ¼ .038). Similarly, deterioration of renal function (2.3% vs 9.5%; P < .001) and new dialysis requirement (1.3% vs 6.1%; P < .001) occurred less frequently after complex EVAR than after complex open repair. Complex EVAR was also associated with lower rates of ischemic colitis (1.0% vs 4.6%; P ¼ .002), myocardial infarction (0.7% vs 4.3%; P ¼ .001), pneumonia (1.2% vs 7.6%; P < .001), prolonged ventilator dependence (1.9% vs 14.4%; P < .001), reintubation (2.2% vs 9.4%; P < .001), wound dehiscence (0.2% vs 3.0%; P ¼ .001), shock (0.7% vs 2.8%; P ¼ .031), return to the operating room (5.4% vs 13.9%; P < .001), and postoperative blood transfusions (16.3% vs 78.7%; P < .001). ICU and hospital lengths of stay were also significantly shorter for those undergoing complex EVAR compared with complex open repair (1.0 vs 4.7 days, P < .001; 4.1 vs 11.3 days, P < .001, respectively).
Compared with infrarenal EVAR, 30-day mortality was significantly higher after complex EVAR (3.4% vs 1.5%; P ¼ .005). Similarly, complex EVAR was associated with a higher rate of renal function deterioration (2.3% vs 0.9%; P ¼ .007), postoperative blood transfusion (16.3% vs 10.2%; P < .001), and prolonged ventilator dependence (1.9% vs 0.9%; P ¼ .036). In addition, lengths of stay in the ICU (1.0 vs 0.6 days, P ¼ .003) and hospital (4.1 vs 2.9 days, P ¼ .001) were both significantly longer after complex EVAR than after infrarenal EVAR.
Outcomes of patients receiving the Zenith Fenestrated endograft are reported in Table III When complex and infrarenal EVAR were compared, infrarenal EVAR was associated with favorable 30-day mortality (OR, 0.5; 95% CI, 0.2-0.9) and renal outcome (OR, 0.4; 95% CI, 0.2-0.9), but no difference was found in the occurrence of any complication (OR, 0.8; 95% CI, 0.6-1.2). Given the invasive nature of open AAA repair and the routine need for postoperative blood transfusions, a postoperative transfusion was not included as a complication in this analysis. However, when a blood transfusion is considered a complication, complex EVAR is associated with an increased risk of any complication compared with infrarenal EVAR as well (OR, 0.7; 95% CI, 0.5-0.9). Within the complex EVAR group, multivariate analysis found no differences between patients treated with the Zenith Fenestrated endograft and those treated using other grafts in multivariable analysis.
DISCUSSION
This study demonstrates that EVAR provides a good alternative to open repair for the treatment of complex AAA. In addition to lower 30-day mortality, we found that EVAR was associated with a lower incidence of various adverse outcomes, including acute renal failure, ischemic colitis, return to the operating room, and length of stay. Compared with infrarenal EVAR, complex EVAR was associated with a significantly increased perioperative mortality risk as well as a higher frequency of several other adverse outcomes, most importantly, an increased incidence of postoperative renal dysfunction.
At 3.4%, the mortality after complex EVAR is comparable to previous reports. 22 When absolute rates of postoperative renal dysfunction are compared with prior reports, the occurrence of kidney injuries in this study is relatively low. 22, 23, 38, 39 The present results most likely underestimate the actual incidence in our cohort, which is the result of the relative strict definition for postoperative renal dysfunction used by the NSQIP. In regards to midterm and late renal outcomes, previous studies have reported good patency results of renal stents and chimneys. 13, 25, 26, 38, 40 Although close monitoring of the renal function is required, this further highlights the benefit of EVAR over open repair, particularly for patients with renal impairment. 41 Similar to established short-term perioperative benefits of EVAR for infrarenal AAA, the incidence of adverse events, such as respiratory and wound complications, ischemic colitis, leg ischemia, myocardial infarction, and return to the operating room, were lower for complex EVAR than for open repair. As a result of the less complicated postoperative period and invasiveness of procedure, length of stay after complex EVAR was almost one-third of that after open repair. Because of the exclusion of conversions to open repair, the incidence of adverse outcomes may be relatively low. However, as previous studies have demonstrated, conversion surgery is rare, and most conversions are not performed in an acute setting. 31, 42 As previously suggested, 25, 26 complex EVAR was associated with a higher frequency of postoperative renal dysfunction compared with infrarenal EVAR, although this did not translate into a higher need for dialysis in the postoperative period. This is in contrast to the study by Glebova et al, 27 which showed no difference in renal complications between infrarenal EVAR and fenestrated EVAR using the non-Targeted Vascular NSQIP data set. This difference may be related to the definition for complex EVAR in the present study, which is based on the specific Targeted Vascular NSQIP variable for proximal aneurysm extent, whereas the definition in the Glebova et al 27 study was established from billing coding before fenestrated endografts were commercially available. Several studies have reported differences in outcome between chimney and fenestrated grafts. These studies determined that no difference exists in mortality or in renal end points between chimneys and fenestrated endografts. 33, 43 Unfortunately, we were unable to identify the exact technical approach that was used beyond the type of main body device. Selective analysis of patients receiving the Zenith Fenestrated graft revealed that these patients had a similar, if not lower, mortality rate than the other complex EVAR patients. However, this may simply reflect that those treated otherwise have more complex anatomy and were therefore ineligible for the Zenith Fenestrated graft, which led to a trend towards worse outcomes. Unfortunately we did not have this level of anatomic detail. For other perioperative complications, we found that the Zenith Fenestrated patients had occurrence rates comparable to other complex EVAR patients, including adverse renal outcomes, despite an increased transfusion requirement. This is in line with results from a pooled data analysis on fenestrated stent grafts. 33 This study has several limitations. First, because the NSQIP Targeted Vascular data set is gathered through a registry, under-reporting of events is possible.
Second, we were unable to fully distinguish between treatment approaches in patients undergoing complex EVAR. However, as previously addressed, reports have shown no differences in perioperative outcomes between fenestrated endografts and chimney grafts. 33, 43 Third, as evidenced by the lower-than-expected proportion of complex EVARs undergoing concurrent renal stenting, the capture of this data point was thought to be unreliable and therefore limited our ability to identify snorkel repairs. We believe this is the result of variable reporting of renal stenting based on interpretation of its definition, because NSQIP clinical reviewers are instructed to capture renal stenting for renal artery stenosis. As a result of a lack of detail in CPT codes for endovascular procedures, CPT coding could unfortunately not be used for the documentation of visceral vessel reconstruction in EVAR patients. For complex open repair, we found that 27% of patients underwent visceral artery reconstruction, which is similar to previous reports. 44 Unfortunately, the data set does not document the exact number of visceral artery reconstructions.
Fourth, the NSQIP database lacks data on perioperative endoleaks and long-term outcomes, which precluded us from assessing differences in the occurrence of endoleaks and late reinterventions as well as long-term renal function. This highlights the need for future studies investigating the long-term outcome of EVAR for complex AAA.
Also, since we did not have access to postoperative serum creatinine values, we were unable to redefine renal dysfunction or use standardized formulas consistent with previous studies. In addition, due to the novelty of this recently added vascular module, validation studies have yet to be conducted for it. However, the ability of these same nurse reviewers to accurately abstract data from the medical record for the NSQIP in general has been confirmed previously. [28] [29] [30] Finally, patients were not randomized to undergo open repair or EVAR. Nevertheless, this study provides valuable new data on the operative outcome of complex AAA repair in both the open and endovascular setting, which may add to prospectively conducted research efforts.
CONCLUSIONS
This study demonstrates that as a result of advancements in endovascular treatment techniques, EVAR has become a good alternative to conventional open repair for treatment of anatomically complex aneurysms. Complex EVAR has fewer perioperative complications than complex open repair, but in turn is associated with increased perioperative risks compared with infrarenal EVAR. Further research is warranted to determine whether the favorable outcome of EVAR for complex AAA is maintained during long-term follow-up. 
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